Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nose

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
Circulation Research|April 1, 1992
Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failureT Eschenhagen, U Mende, M Nose, et al.
Japanese Journal of Cancer Research : Gann|July 1, 1993
A novel human monoclonal antibody directed to a tumor-associated antigenT Kudo, S Kobayashi, K Murakami, et al.
Cardiovascular Research|April 1, 1996
Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human heartsB Linck, P Bokník, T Eschenhagen, et al.
Journal of Biochemistry|October 2, 1998
Expression and characterization of a very low density lipoprotein receptor variant lacking the O-linked sugar region generated by alternative splicingH Iijima, M Miyazawa, J Sakai, et al.
Radiation Research|July 17, 1999
Adaptive response in embryogenesis: II. Retardation of postnatal development of prenatally irradiated miceB Wang, H Ohyama, K Haginoya, et al.
Thorax|January 20, 2000
Role of E-selectin in bleomycin induced lung fibrosis in miceA Azuma, S Takahashi, M Nose, et al.
Cancer Research|March 1, 1987
Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridizationN Ohuchi, P H Hand, G Merlo, et al.
Basic Research in Cardiology|January 1, 1992
Regulation and possible functional implications of G-protein mRNA expression in nonfailing and failing ventricular myocardiumT Eschenhagen, U Mende, M Nose, et al.
British Journal of Pharmacology|February 1, 1992
Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failureM Steinfath, W Danielsen, H von der Leyen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1991
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparationsH von der Leyen, U Mende, W Meyer, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Circulation Research|April 1, 1992
Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failureT Eschenhagen, U Mende, M Nose, et al.
Japanese Journal of Cancer Research : Gann|July 1, 1993
A novel human monoclonal antibody directed to a tumor-associated antigenT Kudo, S Kobayashi, K Murakami, et al.
Cardiovascular Research|April 1, 1996
Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human heartsB Linck, P Bokník, T Eschenhagen, et al.
Journal of Biochemistry|October 2, 1998
Expression and characterization of a very low density lipoprotein receptor variant lacking the O-linked sugar region generated by alternative splicingH Iijima, M Miyazawa, J Sakai, et al.
Radiation Research|July 17, 1999
Adaptive response in embryogenesis: II. Retardation of postnatal development of prenatally irradiated miceB Wang, H Ohyama, K Haginoya, et al.
Thorax|January 20, 2000
Role of E-selectin in bleomycin induced lung fibrosis in miceA Azuma, S Takahashi, M Nose, et al.
Cancer Research|March 1, 1987
Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridizationN Ohuchi, P H Hand, G Merlo, et al.
Basic Research in Cardiology|January 1, 1992
Regulation and possible functional implications of G-protein mRNA expression in nonfailing and failing ventricular myocardiumT Eschenhagen, U Mende, M Nose, et al.
British Journal of Pharmacology|February 1, 1992
Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failureM Steinfath, W Danielsen, H von der Leyen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1991
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparationsH von der Leyen, U Mende, W Meyer, et al.
Pageof 21